Developer of small molecule drugs for severe medical conditions. The company offers clinical and preclinical-stage drug candidates with mechanisms of action and novel chemical structures.
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.